Literature DB >> 26722334

Formation of spherical cancer stem-like cell colonies with resistance to chemotherapy drugs in the human malignant fibrous histiocytoma NMFH-1 cell line.

Liang Deng1, Dejian Li1, Wenguang Gu1, Aiguo Liu1, Xiangyang Cheng1.   

Abstract

Various human cancers have been revealed to contain cancer stem-like cells (CSCs) and the spherical colonies that possess stem-like properties and cancer-initiating abilities. Malignant fibrous histiocytoma (MFH) is a common soft-tissue sarcoma, and is considered to be a myxoma due to the observed high-grade lesions. In the present study, the spherical colonies were isolated from a human MFH cell line NMFH-1 using the sphere culture system. These colonies demonstrated stem-like properties, with the ability of self-renewal and strong drug-resistance to doxorubicin and cisplatin. In addition, verapamil, an adenosine triphosphate binding cassette protein transporter protein (ABCG2) inhibitor, enhanced the efficacy of the aforementioned chemotherapy agents. These colonies also demonstrated an increased expression of embryonic stem genes, including Oct3/4, signal transducer and activator of transcription 3, sex determining region Y-box 10 and ABCG2, and stem cell-associated surface markers, such as cluster of differentiation (CD)44 and CD133. These results indicated that NMFH-1 lesions contain cancer stem-like cell populations that demonstrate strong drug resistance, and verapamil enhanced the efficacy of the chemotherapy agents.

Entities:  

Keywords:  bone and soft tissue sarcoma; cancer stem cell; drug resistance; malignant fibrous histiocytoma; tumor; verapamil

Year:  2015        PMID: 26722334      PMCID: PMC4665366          DOI: 10.3892/ol.2015.3712

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  50 in total

1.  Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties.

Authors:  Dario Ponti; Aurora Costa; Nadia Zaffaroni; Graziella Pratesi; Giovanna Petrangolini; Danila Coradini; Silvana Pilotti; Marco A Pierotti; Maria Grazia Daidone
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

2.  A cell-surface molecule involved in organ-specific homing of lymphocytes.

Authors:  W M Gallatin; I L Weissman; E C Butcher
Journal:  Nature       Date:  1983 Jul 7-13       Impact factor: 49.962

3.  Stem-like cells in bone sarcomas: implications for tumorigenesis.

Authors:  C Parker Gibbs; Valery G Kukekov; John D Reith; Olga Tchigrinova; Oleg N Suslov; Edward W Scott; Steven C Ghivizzani; Tatyana N Ignatova; Dennis A Steindler
Journal:  Neoplasia       Date:  2005-11       Impact factor: 5.715

Review 4.  Tumour stem cells and drug resistance.

Authors:  Michael Dean; Tito Fojo; Susan Bates
Journal:  Nat Rev Cancer       Date:  2005-04       Impact factor: 60.716

5.  The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors.

Authors:  Christian W Scharenberg; Michael A Harkey; Beverly Torok-Storb
Journal:  Blood       Date:  2002-01-15       Impact factor: 22.113

Review 6.  ABC multidrug transporters: structure, function and role in chemoresistance.

Authors:  Frances J Sharom
Journal:  Pharmacogenomics       Date:  2008-01       Impact factor: 2.533

7.  Detection of tumor stem cell markers in pancreatic carcinoma cell lines.

Authors:  Monika Olempska; Patricia Alice Eisenach; Ole Ammerpohl; Hendrik Ungefroren; Fred Fandrich; Holger Kalthoff
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2007-02

Review 8.  Selective targeting of cancer stem cells: a new concept in cancer therapeutics.

Authors:  Hasan Korkaya; Max S Wicha
Journal:  BioDrugs       Date:  2007       Impact factor: 5.807

9.  Isolation and characterisation of cancer stem cells from canine osteosarcoma.

Authors:  H Wilson; M Huelsmeyer; R Chun; K M Young; K Friedrichs; D J Argyle
Journal:  Vet J       Date:  2007-09-11       Impact factor: 2.688

10.  A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance.

Authors:  R Allikmets; L M Schriml; A Hutchinson; V Romano-Spica; M Dean
Journal:  Cancer Res       Date:  1998-12-01       Impact factor: 12.701

View more
  6 in total

1.  MLF1 protein is a potential therapy target for lung adenocarcinoma.

Authors:  Xiaojun Li; Shengping Min; Hongtao Wang; Yuanbing Shen; Wei Li; Yuqing Chen; Xiaojing Wang
Journal:  Int J Clin Exp Pathol       Date:  2018-07-01

2.  Selective and Irreversible Induction of Necroptotic Cell Death in Lung Tumorspheres by Short-Term Exposure to Verapamil in Combination with Sorafenib.

Authors:  Juan Sebastian Yakisich; Yogesh Kulkarni; Neelam Azad; Anand Krishnan V Iyer
Journal:  Stem Cells Int       Date:  2017-10-19       Impact factor: 5.443

3.  Malignant fibrous histiocytoma in the right portion of the mandible with metastasis in pancreas.

Authors:  Javier Biurrun Chamale; Marco Bruno; Facundo Mandojana; Llugdar José; Lucas Armando; Doniquian Alejandro
Journal:  Int J Surg Case Rep       Date:  2017-10-12

4.  Salvianolic acid B reverses multidrug resistance in nude mice bearing human colon cancer stem cells.

Authors:  Piaoting Guo; Jianchao Wang; Wencang Gao; Xia Liu; Shaofei Wu; Boshun Wan; Lei Xu; Yanhua Li
Journal:  Mol Med Rep       Date:  2018-05-29       Impact factor: 2.952

5.  Down-Regulation of AKT Signalling by Ursolic Acid Induces Intrinsic Apoptosis and Sensitization to Doxorubicin in Soft Tissue Sarcoma.

Authors:  Victor Hugo Villar; Oliver Vögler; Francisca Barceló; Javier Martín-Broto; Jordi Martínez-Serra; Valentina Ruiz-Gutiérrez; Regina Alemany
Journal:  PLoS One       Date:  2016-05-24       Impact factor: 3.240

Review 6.  Cancer Stem Cells in Soft-Tissue Sarcomas.

Authors:  Paula Martínez-Delgado; Serena Lacerenza; Antonia Obrador-Hevia; Maria Lopez-Alvarez; José L Mondaza-Hernandez; Elena Blanco-Alcaina; Paloma Sanchez-Bustos; Nadia Hindi; David S Moura; Javier Martin-Broto
Journal:  Cells       Date:  2020-06-10       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.